| Idec starts shipping new cancer drug; Biotech: Zevalin is first radioimmunotherapy to reach the market. (Tech Talk).(Brief Article)(Statistical Data Included): ... An article from: San Diego Business Journal | Digitalby Marion Webb (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | CBJ, L.P. | | Page Count: | 3 Pages | | Publication Date: | April 01, 2002 |
|
EDITORIAL REVIEWS | Product Description This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 1, 2002. The length of the article is 635 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Idec starts shipping new cancer drug; Biotech: Zevalin is first radioimmunotherapy to reach the market. (Tech Talk).(Brief Article)(Statistical Data Included)Author: Marion WebbPublication: San Diego Business Journal (Magazine/Journal)Date: April 1, 2002Publisher: CBJ, L.P.Volume: 23 Issue: 13 Page: 8(1)Article Type: Brief Article, Statistical Data IncludedDistributed by Thomson Gale |
|